loadpatents
name:-0.018316984176636
name:-0.0072369575500488
name:-0.0041079521179199
KOVACS; Bruce Patent Filings

KOVACS; Bruce

Patent Applications and Registrations

Patent applications and USPTO patent grants for KOVACS; Bruce.The latest application filed is for "cxcl10 inhibitors".

Company Profile
3.5.13
  • KOVACS; Bruce - Long Beach CA
  • KOVACS; Bruce - Irvine CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
CXCL10 Inhibitors
App 20220202796 - KOVACS; Bruce
2022-06-30
CCL5 Inhibitors
App 20220142961 - KOVACS; Bruce
2022-05-12
CCL5 inhibitors
Grant 11,318,111 - Kovacs May 3, 2
2022-05-03
CCL2 Inhibitors
App 20220055981 - KOVACS; Bruce ;   et al.
2022-02-24
Compositions And Methods For Treating Skin Conditions, Acne Form Lesions, And Acne
App 20220008497 - KOVACS; Bruce
2022-01-13
CXCL10 Inhibitors
App 20210338650 - KOVACS; Bruce
2021-11-04
CCL2 inhibitors
Grant 11,130,729 - Kovacs , et al. September 28, 2
2021-09-28
CCL5 Inhibitors
App 20210196665 - KOVACS; Bruce
2021-07-01
CCL5 inhibitors
Grant 10,940,132 - Kovacs March 9, 2
2021-03-09
Ccl2 Inhibitors
App 20200181062 - KOVACS; Bruce ;   et al.
2020-06-11
Ccl5 Inhibitors
App 20200138766 - KOVACS; Bruce
2020-05-07
High Mobility Group B1 Protein Inhibitors
App 20200039922 - KOVACS; Bruce ;   et al.
2020-02-06
Use Of Isoindoles For The Treatment Of Neurobehavioral Disorders
App 20180098970 - KOVACS; Bruce ;   et al.
2018-04-12
Use Of Isoindoles For The Treatment Of Neurobehavioral Disorders
App 20090318520 - Kovacs; Bruce ;   et al.
2009-12-24
Treatment of oppositional defiant disorder and conduct disorder with 5-aminoalkyl-4,5,6,7-tetrahydro-4-oxyindolones
Grant 6,897,212 - Comings , et al. May 24, 2
2005-05-24
Treatment of oppositional defiant disorder and conduct disorder with 5-aminoalkyl-4,5,6,7-tetrahydro-4-oxyindolones
App 20040116502 - Comings, David E. ;   et al.
2004-06-17
Use of molindone to treat oppositional defiant disorder and conduct disorder
Grant 6,613,763 - Comings , et al. September 2, 2
2003-09-02
Use Of Molindone To Treat Oppositional Defiant Disorder And Conduct Disorder
App 20020156078 - Comings, David E. ;   et al.
2002-10-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed